TRICARE covers GLP-1 medications — but the coverage depends heavily on which TRICARE plan you have, what the drug is prescribed for, and when you became a beneficiary. On August 31, 2025, the Defense Health Agency (DHA) implemented regulatory controls that eliminated weight-loss GLP-1 coverage for TRICARE For Life beneficiaries and others. At the same time, TRICARE Prime and TRICARE Select beneficiaries retained coverage for Wegovy, Zepbound, and other weight-loss medications with prior authorization.
This guide maps TRICARE GLP-1 coverage by plan type, details the prior authorization and step therapy requirements, explains what changed in August 2025, and identifies what prescribers, benefit verification teams, and TRICARE beneficiaries should monitor. It is independent information and not medical advice or reimbursement guidance for a specific patient or plan.
Quick answer
| TRICARE Plan | Weight-Loss GLP-1 Coverage | T2D GLP-1 Coverage | Key Change |
|---|---|---|---|
| TRICARE Prime | Covered with PA | Covered with PA | No change; PA criteria updated Aug 31, 2025 |
| TRICARE Prime Remote | Covered with PA | Covered with PA | No change |
| TRICARE Select | Covered with PA | Covered with PA | No change |
| US Family Health Plan | Covered with PA | Covered with PA | No change |
| TRICARE Young Adult | Covered with PA | Covered with PA | No change |
| TRICARE Reserve Select | Covered with PA | Covered with PA | No change |
| TRICARE Retired Reserve | Covered with PA | Covered with PA | No change |
| Continued Health Care Benefit Program | Covered with PA | Covered with PA | No change |
| TRICARE For Life | Not covered (as of Aug 31, 2025) | Covered with PA | Weight-loss coverage eliminated |
| Direct-care-only beneficiaries | Not covered | Covered through military pharmacies | Weight-loss drugs excluded |
| NATO/Partnership for Peace | Not covered | Covered | Weight-loss drugs excluded |
Who this is for
- TRICARE beneficiaries navigating GLP-1 coverage across different plan types
- Prescribers treating TRICARE patients who need GLP-1 medications for diabetes, obesity, cardiovascular risk, or sleep apnea
- Benefit verification and prior authorization specialists handling TRICARE pharmacy claims
- Military treatment facility pharmacists processing GLP-1 prescriptions
- Market access teams at GLP-1 manufacturers tracking government payer policy
- Veterans service organizations and military advocacy groups assisting beneficiaries
Source standard
Every fact in this guide is sourced from TRICARE.mil, the Defense Health Agency, Express Scripts TRICARE pharmacy materials, and official Department of Defense publications dated 2025–2026. TRICARE coverage rules are set by DHA under authority of 32 CFR §199.17(f)(3). Always verify current formulary and PA criteria using the TRICARE Formulary Search tool or by contacting Express Scripts.
What changed August 31, 2025
On August 31, 2025, DHA began implementing revised regulatory controls on weight-loss medication coverage. The key changes:
- TRICARE For Life beneficiaries lost weight-loss GLP-1 coverage: All previously approved prior authorizations for weight-loss drugs became invalid. TFL beneficiaries must now pay 100% of the cost for weight-loss medications, even if they had an approved PA before August 31, 2025
- Military pharmacy fills eliminated for weight-loss drugs: Weight-loss medications can no longer be filled at military pharmacies, regardless of beneficiary category
- Prior authorization criteria updated: Clinical criteria for weight-loss drug PA became more specific, with stricter documentation requirements
- Prime and Select unchanged for weight-loss coverage: TRICARE Prime and TRICARE Select beneficiaries retained weight-loss GLP-1 coverage, subject to updated PA criteria
The change was implemented under existing statutory and regulatory authority (32 CFR §199.17(f)(3)) and was announced on August 5, 2025, via TRICARE.mil and DHA newsroom.
Dr. Paul Cordts, Defense Health Agency Chief Medical Officer, stated: "People are taking GLP-1 drugs — like Wegovy and Zepbound — for weight loss now more than ever. It's important to understand how — and why — TRICARE covers these drugs, based on your condition and status."
GLP-1 coverage by drug and indication
Weight-loss GLP-1s (Wegovy, Zepbound, Saxenda)
TRICARE covers these medications for chronic weight management when prescribed by a TRICARE network provider with approved prior authorization for eligible plan types (Prime, Select, and premium-based plans).
- Wegovy (semaglutide 2.4 mg injection): Covered for chronic weight management and cardiovascular risk reduction. Tier 2 formulary. PA required.
- Zepbound (tirzepatide injection): Covered for chronic weight management and obstructive sleep apnea. Tier 2 formulary. PA required.
- Saxenda (liraglutide 3 mg injection): Covered for chronic weight management. Requires PA and medical necessity form.
Diabetes GLP-1s (Ozempic, Mounjaro, Trulicity, Victoza)
TRICARE covers these medications for type 2 diabetes across all plan types, including TRICARE For Life, with prior authorization.
- Ozempic (semaglutide injection): Covered for T2D. PA required.
- Mounjaro (tirzepatide injection): Covered for T2D. PA required.
- Trulicity (dulaglutide injection): Covered for T2D. Lower copayment. PA required unless documentation of another diabetes drug in TRICARE pharmacy record within the past 720 days.
- Victoza (liraglutide injection): Covered for T2D. PA required.
Important: Ozempic is covered only for type 2 diabetes. Wegovy is the semaglutide product covered for weight loss. TRICARE treats the two formulations differently based on their FDA-approved indications, even though they share the same active ingredient.
Other weight-loss medications
TRICARE also covers the following non-GLP-1 weight-loss medications with PA for eligible plans:
- Contrave (naltrexone/bupropion)
- Qsymia (phentermine/topiramate)
- Phentermine (generic and branded forms including Adipex-P, Lomaira)
- Benzphetamine, diethylpropion, phendimetrazine
Prior authorization requirements
For weight-loss GLP-1s (Wegovy, Zepbound)
TRICARE's prior authorization for weight-loss GLP-1 medications requires:
BMI documentation:
- Adults: BMI ≥ 30 kg/m², OR BMI ≥ 27 kg/m² with at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, sleep apnea, coronary heart disease)
- Pediatrics (Wegovy only, ages 12–17): BMI ≥ 95th percentile standardized for age and sex
Step therapy requirement:
- A 12-week trial of phentermine, benzphetamine, diethylpropion, or phendimetrazine (immediate-release or sustained-release) — OR documented adverse reaction or contraindication to these agents
- Some TRICARE regions require trial of multiple agents before GLP-1 approval
Prescriber requirements:
- Prescription must be from a TRICARE network provider
- Provider must complete the PA form and, for Saxenda, a medical necessity form
Lifestyle modification documentation:
- Participation in complementary nutritional and lifestyle changes (dietary modification, increased physical activity, structured behavioral intervention)
Reauthorization:
- PAs are typically renewed yearly
- Continued participation in lifestyle modification must be documented
- Some plans require documented weight loss for renewal
For diabetes GLP-1s (Ozempic, Mounjaro, Trulicity, Victoza)
- T2D diagnosis documentation: Prescriber must submit diagnosis of type 2 diabetes
- Prior therapy: For some agents, documentation of trial with metformin or evidence of contraindication; may require trial and failure of preferred agents (e.g., Trulicity, Ozempic) before non-preferred agents are approved
- Ongoing reauthorization: Periodic renewal of PA with documentation of continued medical necessity
PA forms
PA forms are available through the TRICARE Formulary Search tool at TRICARE.mil. Forms vary by region and may be specific to the TRICARE contractor (e.g., Martin's Point US Family Health Plan has its own PA form for GLP-1s and weight-loss agents).
Cost-sharing by plan type
| Plan Type | Typical Copay (Retail) | Typical Copay (Home Delivery) | Notes |
|---|---|---|---|
| TRICARE Prime | Tier 2 copay | Lower home delivery copay | Active duty: lowest costs |
| TRICARE Select | Cost-share percentage | Lower cost-share | Depends on sponsor status |
| TRICARE For Life | 100% for weight-loss drugs | 100% for weight-loss drugs | T2D drugs still covered |
| TRICARE Reserve Select | Copay | Copay | Same as Select |
| TRICARE Young Adult | Copay | Copay | Same as underlying plan type |
Active duty service members typically have the lowest out-of-pocket medication costs. Exact copays vary by formulary tier and pharmacy type (retail vs. home delivery). Use the TRICARE Formulary Search tool for specific cost information.
How to navigate TRICARE GLP-1 coverage
Step 1: Confirm your TRICARE plan type
Determine whether you are enrolled in TRICARE Prime, TRICARE Select, TRICARE For Life, or a premium-based plan. This determines whether weight-loss GLP-1 coverage is available at all.
Step 2: Use the TRICARE Formulary Search
Search for your specific GLP-1 drug at TRICARE.mil to find:
- Formulary tier
- PA requirements
- Required PA forms
- Quantity limits
Step 3: Work with a TRICARE network provider
Weight-loss GLP-1 prescriptions must be from a TRICARE network provider. Off-network prescriptions will not be covered for weight-loss indications.
Step 4: Submit prior authorization
Your provider must complete and submit the PA form. For diabetes GLP-1s, include the T2D diagnosis documentation. For weight-loss GLP-1s, include BMI documentation, comorbidity evidence, step therapy history, and lifestyle modification participation.
Step 5: Fill the prescription
Weight-loss GLP-1 medications cannot be filled at military pharmacies (as of August 31, 2025). Use retail network pharmacies or Express Scripts home delivery.
TRICARE For Life: impact of the August 2025 change
The elimination of weight-loss GLP-1 coverage for TRICARE For Life beneficiaries has been the most significant recent policy change. TFL beneficiaries who were previously receiving Wegovy or Zepbound for weight management received notification that their coverage would end.
Key details:
- Previously approved PAs for weight-loss drugs are no longer valid
- TFL beneficiaries must pay 100% of the cost for weight-loss GLP-1s
- T2D GLP-1s (Ozempic, Mounjaro, Trulicity, Victoza) remain covered with PA
- Office visits related to weight management remain covered by TFL — only the medication coverage changed
- Military Officers Association of America (MOAA) has been advocating to restore GLP-1 coverage for all TRICARE pharmacy users, calling the change "unfair treatment of military retirees and their family members"
Self-pay alternatives for TFL beneficiaries include:
- Manufacturer savings programs (Novo Nordisk Wegovy savings card, Eli Lilly Zepbound savings card)
- Compounded GLP-1 alternatives through licensed telehealth providers (subject to separate regulation)
- Other weight-management approaches covered by TRICARE (nutrition counseling, lifestyle programs)
TRICARE vs. CHAMPVA vs. VA health care: GLP-1 comparison
| Feature | TRICARE (Prime/Select) | CHAMPVA | VA Health Care |
|---|---|---|---|
| Weight-loss GLP-1 | Covered with PA | Not covered | Case-by-case with documented medical necessity |
| T2D GLP-1 | Covered with PA | Covered with T2D diagnosis | Covered |
| Wegovy for MACE | Covered for eligible plans | Covered | May be covered |
| Zepbound for OSA | Covered for eligible plans | Covered | May be covered |
| Pharmacy administrator | Express Scripts | OptumRx | VA pharmacy |
| Military pharmacy fills | No longer available for weight-loss drugs | Not applicable | Available |
| TFL weight-loss coverage | Not covered (Aug 2025) | Not applicable | Not applicable |
Common denial scenarios
"Weight-loss drug not covered for your plan type"
TRICARE For Life and direct-care-only beneficiaries will receive this denial. Options:
- Switch to a covered T2D GLP-1 if you have type 2 diabetes
- Pursue Wegovy for cardiovascular risk reduction (if you have established CVD)
- Use manufacturer savings programs
- Contact MOAA or your congressional representatives to support restoration efforts
"Prior authorization denied — step therapy not met"
The prescriber must document a 12-week trial of a conventional weight-loss medication (phentermine, benzphetamine, diethylpropion, or phendimetrazine) before TRICARE will approve a GLP-1 for weight loss. If the patient had a contraindication or adverse reaction, document that instead.
"Prescription from non-network provider"
Weight-loss GLP-1 prescriptions must be from a TRICARE network provider. Switch to a network provider or ask your current provider to join the TRICARE network.
What to monitor
- Legislative action: MOAA and other organizations are advocating for restoration of weight-loss GLP-1 coverage for TRICARE For Life. Congressional action could reverse the August 2025 change
- New FDA indications: As GLP-1 drugs receive additional approvals, TRICARE may update coverage criteria
- Formulary changes: Express Scripts updates the TRICARE formulary periodically; Wegovy and Zepbound tier placement could change
- Medicare GLP-1 Bridge: Starting July 2026, CMS will offer $50/month GLP-1 access for eligible Medicare beneficiaries. TFL beneficiaries who are also Medicare-eligible may benefit
- DoD budget pressures: Continued cost pressures on the defense health budget could lead to further restrictions
Sources
- TRICARE.mil. "Does TRICARE cover Wegovy, Ozempic, and Mounjaro?" Last updated November 14, 2025. https://tricare.mil/FAQs/Pharmacy/PharmProg_Wegovy
- TRICARE.mil. "Weight Loss Products." Last updated December 4, 2025. https://tricare.mil/weightlossproducts
- TRICARE Newsroom. "TRICARE Coverage of Weight Loss Medications: What To Know." August 5, 2025. https://newsroom.tricare.mil/News/TRICARE-News/Article/4266447
- Express Scripts Military Rx. "Are GLucagon-Like Peptide 1 (GLP-1) and weight loss medications covered through the TRICARE pharmacy benefit?" https://militaryrx.express-scripts.com/faq/are-glucagon-peptide-1-glp-1-and-weight-loss-medications-covered-through-tricare-pharmacy
- MyAirForceBenefits. "TRICARE Coverage of Weight Loss Medications: What To Know." August 5, 2025. https://myairforcebenefits.us.af.mil/TRICARE-Coverage-of-Weight-Loss-Medications-What-To-Know
- MOAA. "Weight-Loss Drug Coverage Ending for TRICARE For Life Users." August 2025. https://www.moaa.org/content/publications-and-media/news-articles/2025-news-articles/health-care-and-earned-benefits/weight-loss-drug-coverage-ends-for-tricare-for-life-users
- Martin's Point Health Care. "TRICARE Prior Authorization Request Form for Wegovy, Zepbound." https://martinspoint.org/-/media/Providers/Documents/TRICARE-Prior-Authorization-Forms_1222/W-to-X/Wegovy-Zepbound-Prior-Authorization-Form.ashx
- CMS.gov. "Coming Soon: CMS to Provide $50 Monthly Access to GLP-1 Medications for Medicare Beneficiaries." 2026. https://www.cms.gov/newsroom/press-releases/coming-soon-cms-provide-50-monthly-access-glp-1-medications-medicare-beneficiaries
